BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24797504)

  • 1. A retrospective study of volume doubling time in surgically resected non-small cell lung cancer.
    Mackintosh JA; Marshall HM; Yang IA; Bowman RV; Fong KM
    Respirology; 2014 Jul; 19(5):755-62. PubMed ID: 24797504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.
    Lindell RM; Hartman TE; Swensen SJ; Jett JR; Midthun DE; Tazelaar HD; Mandrekar JN
    Radiology; 2007 Feb; 242(2):555-62. PubMed ID: 17255425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial 3-dimensional volumetric computed tomography evaluation of lung cancer growth rate in patients with chronic obstructive pulmonary disease findings.
    Tanimoto D; Ito K; Tamada T; Higaki A; Kanki A; Sato T; Noda Y; Higashi H; Nakata M
    J Comput Assist Tomogr; 2012; 36(2):181-6. PubMed ID: 22446356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up.
    Xu DM; van der Zaag-Loonen HJ; Oudkerk M; Wang Y; Vliegenthart R; Scholten ET; Verschakelen J; Prokop M; de Koning HJ; van Klaveren RJ
    Radiology; 2009 Jan; 250(1):264-72. PubMed ID: 18984780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.
    Inoue M; Sawabata N; Takeda S; Ohta M; Ohno Y; Maeda H
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1100-6. PubMed ID: 15052208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomography reduce the need for invasive procedures?
    Metin M; Citak N; Sayar A; Pekcolaklar A; Melek H; Kök A; Gurses A
    J Thorac Oncol; 2011 Oct; 6(10):1713-9. PubMed ID: 21716145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial.
    van't Westeinde SC; de Koning HJ; Thunnissen FB; Oudkerk M; Groen HJ; Lammers JW; Weenink C; Vernhout R; Nackaerts K; Mali W; van Klaveren RJ
    J Thorac Oncol; 2011 Oct; 6(10):1704-12. PubMed ID: 21876458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer.
    Meng X; Sun X; Mu D; Xing L; Ma L; Zhang B; Zhao S; Yang G; Kong FM; Yu J
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):960-6. PubMed ID: 21440998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete video-assisted thoracoscopic multi-subsegmentectomy based on patients' specific virtual 3-D pulmonary models.
    Kanzaki M; Maeda H; Wachi N; Kikkawa T; Komine H; Isaka T; Oyama K; Murasugi M; Onuki T
    Asian J Endosc Surg; 2013 May; 6(2):110-5. PubMed ID: 23323687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental lung carcinoma detected at CT in patients selected for lung volume reduction surgery to treat severe pulmonary emphysema.
    Rozenshtein A; White CS; Austin JH; Romney BM; Protopapas Z; Krasna MJ
    Radiology; 1998 May; 207(2):487-90. PubMed ID: 9577499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
    Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
    J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiologic features, staging, and operability of primary lung cancer in the Western cape, South Africa: a 1-year retrospective study.
    Nanguzgambo AB; Aubeelack K; von Groote-Bidlingmaier F; Hattingh SM; Louw M; Koegelenberg CF; Bolliger CT
    J Thorac Oncol; 2011 Feb; 6(2):343-50. PubMed ID: 21173714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of the standardized uptake value in FDG-PET with the expression level of cell-cycle-related molecular biomarkers in resected non-small cell lung cancers.
    Nakamura H; Hirata T; Kitamura H; Nishikawa J
    Ann Thorac Cardiovasc Surg; 2009 Oct; 15(5):304-10. PubMed ID: 19901884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of computed tomography morphologic characteristics in stage I non-small-cell lung cancer.
    Meniga IN; Tiljak MK; Ivankovic D; Aleric I; Zekan M; Hrabac P; Mazuranic I; Puljic I
    Clin Lung Cancer; 2010 Mar; 11(2):98-104. PubMed ID: 20199975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
    Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor mutations: effect on volume doubling time of non-small-cell lung cancer patients.
    Nakamura R; Inage Y; Tobita R; Mori K; Numata T; Yanai H; Endo T; Ohtani H; Satoh H; Yuzawa K; Koizumi M; Ueki H
    J Thorac Oncol; 2014 Sep; 9(9):1340-4. PubMed ID: 24481317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.
    Kasprzyk M; Dyszkiewicz W; Piwkowski C; Brudlo M; Galecki B; Gabryel P; Gasiorowski L
    Neoplasma; 2013; 60(1):62-7. PubMed ID: 23067218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of non-small-cell lung cancer during the interval before stereotactic body radiotherapy.
    Murai T; Shibamoto Y; Baba F; Hashizume C; Mori Y; Ayakawa S; Kawai T; Takemoto S; Sugie C; Ogino H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):463-7. PubMed ID: 21095073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.
    O'Callaghan DS; Rexhepaj E; Gately K; Coate L; Delaney D; O'Donnell DM; Kay E; O'Connell F; Gallagher WM; O'Byrne KJ
    Eur Respir J; 2015 Dec; 46(6):1762-72. PubMed ID: 26541534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.